메뉴 건너뛰기
Journal of Medical Economics
Volumn 15, Issue 4, 2012, Pages 664-671
Direct and indirect costs associated with Dupuytren's contracture
Author keywords

Cost; Dupuytren's Contracture; Work loss
Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DUPUYTREN CONTRACTURE; EMERGENCY WARD; EMPLOYEE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PEYRONIE DISEASE; PHYSIOTHERAPY; PRESCRIPTION; PRIVATE HEALTH INSURANCE;
EID: 84862561849     PISSN: 13696998     EISSN: 1941837X     Source Type: Journal    
DOI: 10.3111/13696998.2012.670678     Document Type: Article
Times cited : (17)
References (21)
  • 2
    • 41849100021 scopus 로고    scopus 로고
    • MOC-PSSM CME article: Dupuytren's disease
    • Swartz WM, Lalonde DH. MOC-PSSM CME article: Dupuytren's disease. Plast Reconstr Surg 2008;121(Suppl):1-10
    • (2008) Plast Reconstr Surg , vol.121 , Issue.SUPPL. , pp. 1-10
    • Swartz, W.M.1    Lalonde, D.H.2
  • 3
    • 0035117412 scopus 로고    scopus 로고
    • Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease
    • DOI 10.1080/030097401750065292
    • Gudmundsson KG, Arngrimsson R, Jó nsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease. Scand J Rheumatol 2001;30:31-4 (Pubitemid 32176221)
    • (2001) Scandinavian Journal of Rheumatology , vol.30 , Issue.1 , pp. 31-34
    • Gudmundsson, K.G.1    Arngrimsson, R.2    Jonsson, T.3
  • 4
    • 34250863386 scopus 로고    scopus 로고
    • Efficacy and safety of injectable mixed collagenase subtypes in the treatment of dupuytren's contracture
    • DOI 10.1016/j.jhsa.2007.04.002, PII S0363502307003978
    • Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am 2007;32:767-74 (Pubitemid 46991162)
    • (2007) Journal of Hand Surgery , vol.32 , Issue.6 , pp. 767-774
    • Badalamente, M.A.1    Hurst, L.C.2
  • 5
    • 79955791184 scopus 로고    scopus 로고
    • Prevalence, incidence, and treatments of Dupuytren's disease in the United States: Results from a population-based study
    • DiBenedetti DB, Nguyen D, Zografos L, et al. Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study. Hand (N Y) 2011;6:149-58
    • (2011) Hand (N Y) , vol.6 , pp. 149-58
    • Dibenedetti, D.B.1    Nguyen, D.2    Zografos, L.3
  • 6
    • 68949122984 scopus 로고    scopus 로고
    • Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology
    • Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N Y) 2009;4:256-69
    • (2009) Hand (N Y) , vol.4 , pp. 256-69
    • Hindocha, S.1    McGrouther, D.A.2    Bayat, A.3
  • 8
    • 0017113115 scopus 로고
    • Dupuytren's disease in epilepsy: Result of prolonged administration of anticonvulsants
    • Critchley EM, Vakil SD, Hayward HW, et al. Dupuytren's disease in epilepsy: result of prolonged administration of anticonvulsants. J Neurol Neurosurg Psychiatry 1976;39:498-503
    • (1976) J Neurol Neurosurg Psychiatry , vol.39 , pp. 498-503
    • Critchley, E.M.1    Vakil, S.D.2    Hayward, H.W.3
  • 9
    • 0030897437 scopus 로고    scopus 로고
    • Smoking, alcohol and the risk of Dupuytren's contracture
    • Burge P, Hoy G, Regan P, et al. Smoking, alcohol and the risk of Dupuytren's contracture. J Bone Joint Surg 1997;79:206-10
    • (1997) J Bone Joint Surg , vol.79 , pp. 206-10
    • Burge, P.1    Hoy, G.2    Regan, P.3
  • 10
    • 0042165853 scopus 로고    scopus 로고
    • Musculoskeletal manifestations in patients with thyroid disease
    • DOI 10.1046/j.1365-2265.2003.01786.x
    • Cakir M, Samanci N, Balci N, et al. Musculoskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf) 2003;59:162-7 (Pubitemid 36918651)
    • (2003) Clinical Endocrinology , vol.59 , Issue.2 , pp. 162-167
    • Cakir, M.1    Samanci, N.2    Balci, N.3    Balci, M.K.4
  • 11
    • 0035287910 scopus 로고    scopus 로고
    • The association between frozen shoulder and Dupuytren's disease
    • DOI 10.1067/mse.2001.112883
    • Smith SP, Devaraj VS, Bunker TD. The association between frozen shoulder and Dupuytren's disease. J Shoulder Elbow Surg 2001;10:149-51 (Pubitemid 33602085)
    • (2001) Journal of Shoulder and Elbow Surgery , vol.10 , Issue.2 , pp. 149-151
    • Smith, S.P.1    Devaraj, V.S.2    Bunker, T.D.3
  • 13
  • 14
    • 0033750268 scopus 로고    scopus 로고
    • The injection of nodules of Dupuytren's disease with triamcinolone acetonide
    • Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am 2000;25:1157
    • (2000) J Hand Surg Am , vol.25 , pp. 1157
    • Ketchum, L.D.1    Donahue, T.K.2
  • 15
    • 79955514333 scopus 로고    scopus 로고
    • The treatment of Dupuytren disease
    • Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am 2011;36:936-42
    • (2011) J Hand Surg Am , vol.36 , pp. 936-42
    • Desai, S.S.1    Hentz, V.R.2
  • 16
    • 84862555019 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. FDA Approves Xiaflex for Debilitating Hand Condition. FDA News Release. Washington, DC: U.S. Food and Drug Administration Accessed June 29, 2011
    • U.S. Food and Drug Administration. FDA Approves Xiaflex for Debilitating Hand Condition. FDA News Release. Washington, DC: U.S. Food and Drug Administration, 2010. http://www.fda.gov/newsevents/newsroom/pressannouncements/ ucm199736.htm. Accessed June 29, 2011
    • (2010)
  • 17
    • 69949170812 scopus 로고    scopus 로고
    • Injectable collagenase clostridium histolyticum for Dupuytren's contracture
    • Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009; 361:968-79
    • (2009) N Engl J Med , vol.361 , pp. 968-79
    • Hurst, L.C.1    Badalamente, M.A.2    Hentz, V.R.3
  • 18
    • 23944482666 scopus 로고    scopus 로고
    • Dupuytren's disease in France - 1831 to 2001 - From description to economic burden
    • DOI 10.1016/j.jhsb.2005.05.004, PII S0266768105001713
    • Maravic M, Landais P. Dupuytren's disease in France-1831 to 2001-from description to economic burden. J Hand Surg Br 2005;30:484-7 (Pubitemid 41194687)
    • (2005) Journal of Hand Surgery , vol.30 , Issue.5 , pp. 484-487
    • Maravic, M.1    Landais, P.2
  • 19
    • 79953898244 scopus 로고    scopus 로고
    • Dupuytren's contracture: A retrospective database analysis to assess clinical management and costs in England
    • Gerber RA, Perry R, Thompson R, et al. Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England. BMC Musculoskelet Disord 2011;12:73
    • (2011) BMC Musculoskelet Disord , vol.12 , pp. 73
    • Gerber, R.A.1    Perry, R.2    Thompson, R.3
  • 20
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • DOI 10.1016/0021-9681(87)90171-8
    • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83 (Pubitemid 17055592)
    • (1987) Journal of Chronic Diseases , vol.40 , Issue.5 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.A.3    MacKenzie, C.R.4
  • 21
    • 0027445675 scopus 로고
    • Adapting a clinical comorbidity index for use with ICD-9-CM administrative data
    • Romano PS, Roos LL, Jollis J. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1993;46:1075-9
    • (1993) J Clin Epidemiol , vol.46 , pp. 1075-9
    • Romano, P.S.1    Roos, L.L.2    Jollis, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.